Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Other Working Capital Changes (2016 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Other Working Capital Changes for 13 consecutive years, with -$714000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes fell 103.37% year-over-year to -$714000.0, compared with a TTM value of $4.4 million through Dec 2025, down 75.21%, and an annual FY2025 reading of $4.4 million, down 75.21% over the prior year.
  • Other Working Capital Changes was -$714000.0 for Q4 2025 at Tandem Diabetes Care, up from -$3.3 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $24.1 million in Q3 2022 and bottomed at -$22.4 million in Q4 2022.
  • Average Other Working Capital Changes over 5 years is $2.4 million, with a median of $602500.0 recorded in 2021.
  • Peak annual rise in Other Working Capital Changes hit 9076.43% in 2022, while the deepest fall reached 3290.91% in 2022.
  • Year by year, Other Working Capital Changes stood at $2.2 million in 2021, then plummeted by 1097.9% to -$22.4 million in 2022, then skyrocketed by 151.33% to $11.5 million in 2023, then skyrocketed by 84.5% to $21.2 million in 2024, then tumbled by 103.37% to -$714000.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for TNDM at -$714000.0 in Q4 2025, -$3.3 million in Q3 2025, and $6.1 million in Q2 2025.